Citius Pharmaceuticals, Inc. (CTXR)
NASDAQ: CTXR · Real-Time Price · USD
2.600
+0.030 (1.17%)
At close: Dec 20, 2024, 4:00 PM
2.570
-0.030 (-1.15%)
After-hours: Dec 20, 2024, 4:40 PM EST
Citius Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Jun '24 Jun 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | Sep '19 Sep 30, 2019 |
| Net Income | -38.29 | -32.54 | -33.64 | -23.05 | -17.55 | -15.56 | |
| Depreciation & Amortization | 0.21 | 0.19 | 0.18 | 0.16 | 0.15 | 0 | |
| Stock-Based Compensation | 12.56 | 6.72 | 4.28 | 1.52 | 1.33 | 0.93 | |
| Other Operating Activities | 0.58 | 0.58 | 0.58 | -0.17 | - | - | |
| Change in Accounts Receivable | - | - | - | - | - | 0.82 | |
| Change in Accounts Payable | -1.42 | 1.76 | -0.11 | -0.58 | -0.86 | 1.14 | |
| Change in Other Net Operating Assets | -2.72 | -5.77 | 0.35 | -2.14 | -0.01 | 0.24 | |
| Operating Cash Flow | -29.09 | -29.06 | -28.36 | -24.25 | -16.93 | -12.44 | |
| Capital Expenditures | - | - | - | -0.01 | -0 | - | |
| Sale (Purchase) of Intangibles | - | - | - | -40 | - | - | |
| Investing Cash Flow | - | - | - | -40.01 | -0 | - | |
| Long-Term Debt Issued | - | - | - | - | 0.16 | - | |
| Total Debt Issued | - | - | - | - | 0.16 | - | |
| Short-Term Debt Repaid | - | - | - | -0.17 | - | - | |
| Total Debt Repaid | - | - | - | -0.17 | - | - | |
| Net Debt Issued (Repaid) | - | - | - | -0.17 | 0.16 | - | |
| Issuance of Common Stock | 14.92 | 15.03 | - | 127.71 | 24.27 | 11.15 | |
| Other Financing Activities | -1.2 | -1.2 | - | -7.07 | -1.54 | - | |
| Financing Cash Flow | 13.72 | 13.83 | - | 120.47 | 22.9 | 11.15 | |
| Net Cash Flow | -15.37 | -15.23 | -28.36 | 56.21 | 5.97 | -1.29 | |
| Free Cash Flow | -29.09 | -29.06 | -28.36 | -24.26 | -16.93 | -12.44 | |
| Free Cash Flow Per Share | -4.47 | -4.80 | -4.85 | -5.58 | -10.81 | -15.42 | |
| Cash Interest Paid | - | - | - | 0.04 | - | - | |
| Levered Free Cash Flow | -16.83 | -19.85 | -15.94 | -55.61 | -10.34 | -6.58 | |
| Unlevered Free Cash Flow | -16.83 | -19.85 | -15.94 | -55.61 | -10.33 | -6.57 | |
| Change in Net Working Capital | 3.92 | 3.81 | -0.42 | 2.58 | 0.74 | -2.25 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.